ELIGLUSTAT

1659 reported adverse events

Drug classes: Glucosylceramide Synthase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ELIGLUSTAT:

# Side effect Count
0 WEIGHT INCREASED 175
1 PRODUCT DOSE OMISSION IN ERROR 162
2 WEIGHT DECREASED 150
3 FATIGUE 79
4 PRODUCT DOSE OMISSION ISSUE 76
5 DYSPEPSIA 54
6 ARTHRALGIA 53
7 FALL 53
8 NAUSEA 51
9 DIZZINESS 45
See all common reactions for ELIGLUSTAT

ELIGLUSTAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHITOTRIOSIDASE DECREASED 2 1.0000
1 BONE CRISIS 2 0.5000
2 GLUCOSYLSPHINGOSINE INCREASED 3 0.3333
3 ANTI-GLYCYL-TRNA SYNTHETASE ANTIBODY POSITIVE 1 0.3333
4 SHORT-CHAIN ACYL-COENZYME A DEHYDROGENASE DEFICIENCY 1 0.2000
5 CHITOTRIOSIDASE INCREASED 9 0.1475
6 PYRUVATE KINASE INCREASED 1 0.0909
7 PHARYNGEAL LEUKOPLAKIA 2 0.0741
8 PERFUSION BRAIN SCAN ABNORMAL 1 0.0714
9 LYSOSOMAL STORAGE DISORDER 1 0.0526
See all enriched reactions for ELIGLUSTAT